Want to contact a District of Columbia Sinemet attorney? ...Get a free case evaluation from one of our District of Columbia Sinemet attorneys now.

Sinemet - News Articles

Times Leader | Living | Reno takes on Parkinson’s with curiosity
May 15, 2007
Wilkes Barre Times-Leader, PA -
A: I take Sinemet (a common medication with levodopa). I took Miraplex for a while but had to give it up. Q: I took Requip at first but had to stop because ...
Health Insurance
May 15, 2007
Health Insurance and Protection Magazine, UK -
Drugs that may have a temporary or modest benefit are levodopa (as in Sinemet), amantadine, and amitriptyline. Botulinum toxin injections are sometimes used to treat the blepharospasm (involuntary eyelid closure) that occurs in some people with PSP. Artificial tears can be used ...
Technology Review: Michael J. Fox asks researchers, investors to speed therapies for diseases like Parkinson's
May 7, 2007
MIT Technology Review, MA -
''Levodopa is the gold-standard treatment for Parkinson's But it's a little frustrating that the best drug we've got is one that's been around for 40 years. 40 years!'' Fox said Monday at the BIO International Convention, a four-day event expected to attract more than ...
Fox urges researchers to speed therapies
May 7, 2007
Brocktown News, NV -
"Levodopa is the gold-standard treatment for Parkinson‘s But it‘sa little frustrating that the best drug we‘ve got is one that‘s been around for 40 years. 40 years!" Fox said Monday at the BIO International Convention, a four-day event expected to attract more than ...
KSTP.com - Fox Urges Researchers to Speed Therapies
May 7, 2007
KSTP.com, MN -
"Levodopa is the gold-standard treatment for Parkinson’s But it’sa little frustrating that the best drug we’ve got is one that’s been around for 40 years. 40 years!" Fox said Monday at the BIO International Convention, a four-day event expected to attract more than ...
News - High-Frequency Stimulation Provides Long-Term Efficacy for Parkinson's Symptoms: Presented at AANS
May 4, 2007
DG News -
Drug dosages, and subsequently the levodopa-induced dyskinesias, were decreased by an average of 65%. This was linearly correlated to the preoperative levodopa-induced improvement and was strictly dependent on the accurate placement of the leads, according to the researchers.The benefit of ...
CTV.ca | Fox urges researchers to speed therapies
May 8, 2007
CTV.ca, Canada -
"Levodopa is the gold-standard treatment for Parkinson's But it's a little frustrating that the best drug we've got is one that's been around for 40 years. Forty years!" Fox said Monday at the BIO International Convention, a four-day event expected to attract more than ...
Fox: Take risks in fight vs. diseases - Business - BostonHerald.com
May 7, 2007
Boston Herald, MA -
“Levodopa is the gold-standard treatment for Parkinson’s,” said Fox, who has established his own foundation to help fund studies of the disease that’s ...
News - Istradefylline Improves Motor Function in Parkinson's Patients Experiencing "Off" Time: Presented at AAN
May 7, 2007
DG News -
BOSTON, MA -- May 7, 2007 -- Istradefylline, a novel adenosine A2A receptor antagonist, appears to reduce the wearing off time associated with levodopa and other anti-Parkinson's medications when administered at 20 mg/day to Parkinson's patients, according to results of a multicenter, phase 3, ...
Charleston Daily Mail
May 9, 2007
Daily Mail - Charleston, WV -
by AP. BOSTON -- Actor Michael J. Fox appealed to scientists and investors to aggressively translate scientific research into creative treatments for debilitating diseases, including the Parkinson's disease he has fought for more than a decade.Fox said grants from the National ...
Rotigotine As Levodopa Adjunct Is Effective In Advanced Parkinson's Disease
May 3, 2007
Medical News Today, UK -
Transdermal rotigotine (Neupro) up to doses of 8 and 12 mg/day as adjunctive therapy to levodopa significantly decreases "off time" in patients with ...
Seminar shares latest breakthroughs in fight against Parkinson's
May 4, 2007
Simi Valley Acorn, CA -
The drug Sinemet, he said, used in combination with newer drugs to optimize treatment, is still the gold standard for treating motor-skill symptoms. Hutchman said patients in his practice who worked in mines, foundries, chemical factories and welding ...
Reno Is Taking On Her Disease | theledger.com
May 8, 2007
The Ledger, FL -
A. I take Sinemet (a common medication with levodopa). I took Miraplex for a while but had to give it up. Q. I took Requip at first but had to stop because it made me so sleepy. Now I take Azilect.A. I had the same problem with Miraplex: falling asleep. Of ...
Lonnie Ali Champions 'Fight For MORE' Campaign
Apr 26, 2007
Earthtimes.org -
Doctors may recommend adding Zelapar to levodopa/carbidopa treatment when patients are experiencing a reduced response to this therapy. Do not take Zelapar if you are allergic to selegiline or any of the other ingredients in Zelapar. Zelapar ...
Study Probes Parkinson Drugs' Effect on Motivation
Apr 26, 2007
CBC News, Canada -
One group received levodopa, which increases dopamine levels in the brain. The second group received a dopamine receptor blocker called haloperidol (which decreases dopamine activity), while the third group received a placebo.The participants were shown symbols associated with winning or losing ...
News - Dopamine-Related Drugs Affect Reward-Seeking Behavior
Apr 27, 2007
DG News -
One group was given levodopa, a drug that increases dopamine levels in the brain. Another took haloperidol, a dopamine receptor blocker. The third was given a placebo. Dopamine is a chemical naturally produced by the body that transmits signals between ...
Mind games | Health | The Australian
Apr 27, 2007
The Australian, Australia -
Levodopa is the most widely used medication, improving symptoms in more than 80 per cent of people within six to eight weeks. Levodopa is converted into dopamine by nerve cells in the brain. To prevent it from being converted to dopamine before it reaches the ...
Not about getting old ...
Apr 28, 2007
Malaysia Star, Malaysia -
Dr Chew said a new three-in-one drug comprising a pharmacokinetically enhanced levodopa therapy comprising levodopa, carbidopa and entacapone was available and most effective in the treatment of PD.  Clinical benefits demonstrated include longer period without symptoms, significantly improved quality ...
Drugs that adjust dopamine levels in the brain greatly affect how people react to success and failure
Apr 29, 2007
News-Medical.net, Australia -
Drugs that adjust dopamine levels in the brain greatly affect how people react to success and failure, according to research that was presented at the American Academy of Neurology's 59th Annual Meeting.In a first-of-its-kind study on humans, researchers measured how dopamine-related drugs affect the ...
United Press International - Health Business - Analysis - Analysis: Brain docs study sleep, exercise
Apr 30, 2007
United Press International -
By ED SUSMAN. BOSTON, April 30 (UPI) -- Getting a good night's sleep after learning something new helps you remember that information, and getting regular exercise appears to ward off or delay Parkinson's disease, researchers said Monday. Those are among the results of studies ...
Want to contact a District of Columbia Sinemet attorney? ...Get a free case evaluation from one of our District of Columbia Sinemet attorneys now.

Pages: Previous   1   2   3   4   5   6   7   8   Next

AddThis Social Bookmark Button

 

Need A Sinemet Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need A Sinemet Lawyer?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Sinemet Case - Submit Your Information Below

Do you need legal assistance with your Sinemet case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Sinemet Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.